| Literature DB >> 24342791 |
Hicham Eddou1, El Mehdi Mahtat1, Hamid Zahid2, Hicham El Maaroufi1, Selim Jennane1, Nezha Messaoudi2, Kamal Doghmi1, Mohamed Mikdame1.
Abstract
Plasma cell leukemia (LP) is a rare hematologic malignancy. Its prognosis is very derogatory. It is defined by the presence in circulating blood of more than 2 G/L plasmocytes or greater than 20% of the total leukocytes. It comes in two forms: secondary plasma cell leukemia complicating multiple myeloma (MM) and primary setting. Its incidence is estimated at 0.9% of patients with acute leukemia and 2-4% of patients with MM. We report, through three observations, the clinical presentation of the plasma cell leukemia, its cytological features, immunophenotypic, physiopathological and therapeutic care.Entities:
Keywords: leukemia; plasma cell; plasmocyte
Mesh:
Substances:
Year: 2013 PMID: 24342791 DOI: 10.1684/abc.2013.0888
Source DB: PubMed Journal: Ann Biol Clin (Paris) ISSN: 0003-3898 Impact factor: 0.459